Prognostic value of the systemic inflammation response index (SIRI) in glioma: A meta-analysis

Lixia Guo, Xudong Cao, Lijun Yang, Xiaoyan Zhu, Lan Liu and Huandong Liu

PLOS ONE, 2026, vol. 21, issue 11, 1-12

Abstract: Objective: To systematically evaluate the predictive value of systemic inflammation response index (SIRI) for the prognosis of glioma patients. Methods: PubMed, Cochrane Library, EMBASE, and Web of Science databases were searched to collect literature on the relationship between SIRI and glioma prognosis from database inception to July 2026. The primary outcome measures were overall survival (OS) and progression-free survival (PFS). STATA 15.0 and Review Manager 5.4 software were used, and random-effects models were employed with pooled hazard ratios (HR) and their 95% confidence intervals (CI) to assess the prognostic value of SIRI. Subgroup analyses, sensitivity analyses, and publication bias assessments were performed. Results: Eight retrospective cohort studies involving 1778 glioma patients were included, forming 12 comparison groups for OS analysis and 4 comparison groups for PFS analysis. Meta-analysis results showed that a higher SIRI was significantly associated with poorer OS (pooled HR = 1.79, 95% CI: 1.34–2.38, P

Date: 2026
References: Add references at CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362113 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 62113&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0362113

DOI: 10.1371/journal.pone.0362113

Access Statistics for this article

More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().